Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
155 Cards in this Set
- Front
- Back
regulation of biological process |
1. hormones 2. nt 3. histamine prostaglandins |
|
Brain and Spinal Cord |
CNS, incased in bondy strucutre |
|
Peripheral |
that comes out from CNS nerves (what extends from the brain) |
|
Cranial nerve, optic nerve, vagus nerve |
controll all function of body while at rest |
|
peripheray |
afferent sensory ex: posture, , unconsicioulsy sending signals from outside to inside |
|
afferent neurons |
sensory |
|
efferent neurons |
motor |
|
autonomic nerrvous system |
homeostasis 1. parasympathetic 2. sympathetic 3. enteric |
|
somatic nervous system |
skeletal muscle |
|
sympathetic |
anatomically designed to produce widespread physiological activity thoraco-lumbar division |
|
parasympathetic |
anatomically designed to produce response on an organ basis cranio-sacral divisoin |
|
nt 2 |
sympathetic neuron= norepinephrine cholinergic neuron= acetylcholine
|
|
neurotransmission |
1. preganglionic synapse 2. postganglionic synapse 3. somatic motor end plates |
|
norepinephrine |
sympathetic, adrenaline, produced by adrenal gland WIDE SPREAD EFFECT |
|
acetylcholin |
cholinergic neuron, stimulate skeletal muscle tissue, targets motors |
|
receptors |
1.coupled to ion channels 2. coupled to adenyly cyclase 3. coupled to diaclyglycerol |
|
indirectt |
hormones like ADH, bind as surface receptor and secondary messenger regulate vasopressins |
|
innervation |
most visceral organs receive dual innervation both working in opposition (balanced) the one exerting the greater function will prevail
|
|
specific effects of blood vessels: |
innervated by sympathetic, maintains smooth muscle tone |
|
innervation specific effects: heart and cardiovascular reflex |
2- Heart
|
|
innervation specific effects: eye |
4- Eye
|
|
innervation specific effects: lung and GI tract |
5- Lung
|
|
innervation specific effects: salivary glands and adrenal medulla |
7- Salivary glands
|
|
chemical synapses |
1. one way transmission 2. promotes a response in post-synaptic target |
|
cholingeric neuron |
actylcholine produced by modification of acetylco-A Krebs cycle |
|
muscarinic receptors |
wider effects than acetylcholine, have mild nicotine rxns |
|
nicotinic receptors |
stronger response to nicotine than acetylcholine have mild effect to muscarine |
|
adrenergic neuron |
tyrosine is the building block for pigment of skin, IS RATE LIMITING STEP Dopamine- is nt in brain, regulates and counteracts balance of brain parkinson's disease: lose dopa, lose control over skeletal muscle tissue Dopamine make norepinephrine |
|
presynaptic cleft |
3 outcomes: 1. binding to post syn receptor 2. catabolism of excess inside cleft by COMT and MAO 3. may be recycled back to presynaptic neuron |
|
adrenrergic drugs |
adrenergic neuron release norepinephrine in CNS drugs act on receptors stimulated by: epinephrine and norepinephrine |
|
biotransformation |
COMT MAO enzymes that degrade excess in synaptic cleft MAO (metanphrine and VMA) measured in urine |
|
adrenergic receptors alpha |
have higher affinity for epinephrine |
|
adrenergic receptors beta |
have stronger affinity for isoproternol (synthetic) will not be destroyed |
|
alpha 1 adrenoreceptor |
vasoconstriction increase peripheral resistance increased blood pressure mydriasis increased closure of internal urinary bladder sphincter |
|
alpha 2 adrenoreceptor |
inhibition of norepinphrine rlease inhibition of insulin release |
|
beta 1 adrenoreceptor |
tachycardia increased myocardial contractility increased lipolysis |
|
beta 2 adrenoreceptor |
vasodilation slight decrease in peripheral resistance bronchodilation increased glycogenolysis (liver and muscle) increased glucagon release relaxation of uterine smooth muscle |
|
adrenergic receptor desensitization |
prolonged exposure to catecholamines reduces responsiveness of receptor receptor sequestration (less # of receptors on surface) down regulation (respond with lesser strength, but same # of receptors on surface, receptors are LESS SENSITIVE) inability to couple w protein G |
|
adrenergic agonists |
drugs used to replace normal endogenous compound, drugs that mimic resemble in outcome of normal nt |
|
adrenergic agonist |
either indirect direct mixed action
|
|
direct acting adrenergic agonists |
as a group are widely used catecholamines
|
|
catecholamines |
high potency rapid inactivation MAO & COMT Poor penetration into CNS
|
|
Catecholamines Naturally Occuring |
epinephrine norepinephrine dopamine |
|
Catecholamines synthetic compounds |
dobutamine isoproterenol |
|
indirect acting adrenergic agents |
As a group causes release of norepinephrine from presynaptic terminals Cocaine |
|
cocaine |
local anesthetic that blocks Na/K pump required for reuptake of norepinephrine enhancing its sympathetic activity--> so too much nt in synaptic cleft |
|
mixed-action adrenergic agents |
induce norepinephrine release from presynaptic terminals and activate receptors in postsynaptic membranes
|
|
mixed action adrenergic agents 2 |
ephedrine enhance contractility and improve motor function in Myasthenia gravis
metaraminol alternative drug for shock treatment, may be used to treat acute hypotenstion |
|
adrenerrgic agonists side effects: 6 |
arrhtythmias headache hyperactivity insomnia nausea tremors |
|
epinephrine |
interacts with alpha and beta receptors
|
|
epinephrine low and high dose |
low dose- beta receptor activity predominates (vasodilation) high dose- alpha receptor predominates (vasoconstrictor) |
|
actions |
ACTIONS Cardiovascular system (+) inotropic and chronotropic (B1) |
|
actions |
Respiratory system Hyperglycemia Lypolysis (B) |
|
therapeutic use |
Thearpeutic use Bronchospasm (SC) Glaucoma open angle (2% sol) Anesthetics
|
|
pharmacokinetics |
Pharmacokinetics
|
|
norepinephrine |
affects mostly alpha receptors actions: cardiovascular vasoconstriction baroreceptor reflex atropine preteratment if given after atropin it will cause tachycardia |
|
therapeutic use for norepinephrine |
shock (levarterenol) dopamine is better because it doesn't decrease renal blood flow |
|
isoproterenol |
stimulates b1 and b2 actions: cardiovascular (+) inotropic (+) chronotropic decrease peripheral resistance pulmonar bronchodilation |
|
isopreterenol therapeutic use |
asthma heart block or cardiac arrest
pharmacokinetics absorbed systemically by sublingual or aerosols |
|
dopamine |
activates a and b receptors in addition D1 and D2 (mesenteric and renal beds)
|
|
other direct acting agents |
1- Fenlodopan (D1 and A2)
|
|
other direct acting agents |
3- Phenylephrine (A1) 4- Oxymetazoline 5- Methoxamine (A1 > A2) 6- Clonidine (A2)
|
|
Fenlodopan other direct acting agent |
D1 and A2 dopamine agent, which may be implied in hypertension pts that are hospitalized, can increase profusion |
|
Dobutamine |
b1 agonist synthetic agent used to improve cardiac activity in heart failure |
|
phenylephrine |
A1, vasoconstriction, reduces histamine release |
|
oxymetazoline |
nasomucousa, reducing glucosecretions, watery dischage (reduce the discharge), mydriasis, topically
|
|
methoxamine |
A1>A2 parernterally, works by modulating the vasculature, smooth muscle contraction |
|
Clonidine |
A2 HYPERTENSIVE AGENT, slows down function of heart pump, vasodilation |
|
b2 agonist are employed for asthma aerosols for b2 rescue agent |
have effects produce smooth muscle |
|
metaproterenol albuterol, pributerol, salmetrol, formetrol
----------- Terbutaline |
used for bronchodilation -------- bronchodilator, decreases uterine contractions in premature labor |
|
rescue agents bc |
immediate |
|
alpha adrenergic blockers |
decrease sympathetic tone of blood vessels decrease peripheral vascular resistance with reflex tachycardia |
|
as a group act as equilibrium competitors 3 families compete in supply and demand commonly employed for hypertension begins with first making diagnosis from increased blood pressure 130/90 |
1. haloalkylamines 2. imidazolines 3. quinazolines |
|
first step in hypertension |
weightloss, second step is drug |
|
equilibrium competitors haloalkylamine |
phenoxybenzamine (Dibenzyline)
|
|
equilibrium competitors Imidazolines |
phentolamine (Regitine) |
|
Equilibrium competitors Quinazolines |
prazosin (Minipress®)
|
|
phenoxybenzamine |
Phenoxybenzamine |
|
phentolamine |
Phentolamine |
|
Quinazolines Prazosin, terazosin and doxazosin |
(Post synaptic alpha 1 receptors blockers) |
|
w 3 families halo, imi, quin side effects |
hypotension, tachycardia, vertigo, sexual dysfunction |
|
drugs affecting nt release or uptake |
Reserpine Guanethidine |
|
Reserpine |
Reserpine (Serprasil ®) |
|
Guanethidine |
|
|
alpha and beta antagonist |
Alpha and Beta antagonist |
|
beta blockers |
Propranolo Nadolol Timolol Acebutolol Atenolol Esmolol Metaprolol Carvelidol Labetalol |
|
B1 and B2 blockers |
Propranolol Nadolol Timolol |
|
B1 Selective ***ISA*** |
Acebutolol Atenolol Esmolol Metaprolol
|
|
ISA |
Intrinsic sympathetic activity (binds to receptor, but effect has lower strength) |
|
A1, B1, B2 |
Carvelidol Labetalol |
|
Selective |
Acebutolol Atenolol Esmolol Metaprolol
|
|
Non-selective |
Propranolol Nadolol Timolol Carvelidol Labetalol |
|
What happens w insulin secretion? |
beta blockers, beta cells create insulin, may decrease production from pancreas, don't take into consideration |
|
Clinical Use |
CLINICAL USE Supraventricular tachycardias
|
|
Clinical Use |
Angina pectoris
|
|
Clinical Use |
Migrane Thyrotoxicosis |
|
Side effects w beta blockers |
arrhythmias, bronchoconstriction sexual dysfunction |
|
Regulation of Biological Process |
Hormones, Neurotransmitters, Histamine (prostaglandins)inn |
|
innveration |
blood vessels, heart, cardiovascular, eye, lung, GI tract, Salivary Glands, Adrenal Medulla |
|
Cholinergic neuron uses what for a nt? |
acetylcholin |
|
name the 2 receptors of a cholinergic neuron |
muscarinic and nicotinic |
|
adrenergic neuron uses what for nt's? |
epinephrine and dopamine |
|
CNS |
is composed of brain and spinal cored |
|
PNS |
neurons located outside spinal cord |
|
efferent division |
EXIT- carry info (signals) AWAY from brain and spinal cord |
|
afferent |
bring information from PNS to CNS |
|
efferent division divided into |
somatic and autonomic |
|
autonomic divided into |
para symp enteric (endocrine and exocrine), GI tract |
|
sympathetic region |
thoracic and lumbar |
|
parasympathetic region |
cranium and sacral areas |
|
effects of stimulation from sympathetic |
flight or fight increase heart rate, dilation of pupils and bronchioles increase blood pressure |
|
effects of stimulation from sympathetic |
adrenal medulla release epinephrine and less neorephinephrine |
|
parasympathetic |
opposes sympathetic, and dominates over "rest and digest" TO SPECIFIC ORGANS |
|
Hypothalmus, medulla oblongata, and spinal cord |
respond to stimuli by sending out efferent reflex impulses via autonomic nervous system |
|
emotion: rage, fear, pleasure |
can modify autonomic nervous system |
|
dual innervation |
by both para and sum, but one will predominate |
|
controlling heart rate dual innervation |
VAGUS NERVE predominate factor |
|
Organs receiving only sympathetic innveration |
adrenalla medulla, kidney, pilomotor muscles, and sweat glands
and basically control of blood pressure |
|
somatic nervous system |
single myelinated motor neuron, originating in the CNS |
|
Local mediators |
not distributed throughout body, only act locally Histamine and prostaglandins!!** |
|
hormones |
specialized endocrine cells secrete hormones into the bloodstream |
|
2 main nts in autonomic nervous system |
acetylcholine and norepinephrine |
|
cholernergic neurons use |
acetylcholine |
|
adernergic neurons use |
ADRENALINE, epinephrine or norepinephrine |
|
acetylcholine does: |
decrease heart rate and cardiac output decrease blood pressure
|
|
acetylcholine has 2 receptors: |
1. muscarinic 2. nicotinic |
|
M2 |
HEART, brain, autonomic ganglia, and smooth muscle |
|
acetylcholine is not therapeutically important |
because has so many actions |
|
bethanecol |
synthetically related to acetylcholine but not destroyed by acetylcholineterase strong muscarinic action increases intestinal motility and tone stimulate detrussor muscle of bladder promoting urination |
|
carbachol |
muscarinic and nicotinic actions may last up to an 1 hr. |
|
carbachol |
because of its potency and long duration is rarely used except for the eye where causes mitosis ( decrease intraocular pressure) can avoid systemic effects is applied topically |
|
pilocarpine |
for acute angle glaucoma |
|
pilocarpine |
miosis, also stimulates sweat, tears, and saliva production |
|
pilocarpine |
drug of choice for decreasing IOP in emergency treatment of glaucoma |
|
Cholinergic adverse effects |
diarrhea, diaphoresis,miosis, nausea, urinary urgency |
|
reversible: pyridostigmine |
both muscarinic and nicotinic receptors, duration 2-4 hours
|
|
pyridostigmine therapeutic use: |
promotes motility in bladder, decrease IOP topically, antidote for overdose of atropine, phenotiazine, Tricyclic antidepressants
USE IN MYASTHENIA GRAVIS |
|
pyridostigmine adverse effects |
convulsions, bradychardia |
|
Neostigmine |
doesn't cross the blood brain barrier, but has greater effect in skeletal muscle. used in myasthenia gravis and antidote for tobocurarine and neuromuscular blockers |
|
Demecarium |
similar action as Neostigmine but used for open angle glaucoma |
|
Edrophonium |
similar to neostigmine but shorter duration USE IV IN DIAGNOSIS OF MYASTEHNIA |
|
Tarcrine, Donazepil, Rivastigmine, and Galantamine, |
used in treatment of alzheimer's disease |
|
irreversible |
extremely toxic |
|
ecchothiophate irreversible |
covalently binds to active site of acetylcholinesterase and permanently activates. With "age" (loosing of isopropyl group) make is unavailable for activation |
|
ecchothiophate irreversible |
one application lasts up to one week misosis |
|
pralidoxime |
reactivation of acetylcholinesterase but be used before aging |
|
cholinergic agonists |
contraction of visceral smooth muscle miosis hypotension bradycardia |
|
atropine anti muscarinic |
mydriasis cyclopegia used for examination of funds, if pt suffers from glaucoma, might not be used |
|
atropine antimuscarinic |
GI system: antipasmodic CV: low dose--> bradycardia (block M1 receptors) high dose--> tachycardia
xerostomia (dry mouth and eye)
antidote for insecticides |
|
atropine |
if too much, hallucinations |
|
scoplamine |
"scuba" used for motion sickness blocks short term memory can cross blood brain barrier and can produce hallucinations |
|
ipratropium/ tiotropium |
inhalation in asthma and COPD, decrease mucouse production
Topically: Topicamine and Cycopentolate - cyclopegia |
|
benztripine/ trihexyphenidyl |
parkinson disesase |
|
Darifenacin/ Fesoterodine, Oxybutyin/ Solifenacin, Tolterodine |
sythenitch atropin used for over active bladders these drugs reduce hypersensitivity to sensation of having to pee |
|
Cholinergic antagonist side effects |
blurred vision confusion mydriasis constipation urinary retention |